Search results for "Coronavirus"
No benefit found from high-dose steroids, RAS inhibitors in latest COVID-19 trials
Multiple new studies tested renin-angiotensin system (RAS) inhibitors in inpatients with COVID-19, while the latest report from the RECOVERY trial found higher mortality in patients on no or regular oxygen who received high-dose corticosteroids compared to usual care.
https://acphospitalist.acponline.org/archives/2023/04/19/free/no-benefit-found-from-high-dose-steroids-ras-inhibitors-in-latest-covid-19-trials.htm
19 Apr 2023
Remdesivir reduced mortality in inpatients on no or regular oxygen, meta-analysis finds
The patient-level analysis of all available trials of remdesivir still did not have the power to identify any effect of the drug on mortality in COVID-19 patients receiving high-flow oxygen or mechanical ventilation.
https://acphospitalist.acponline.org/archives/2023/03/01/free/remdesivir-reduced-mortality-in-inpatients-on-no-or-regular-oxygen-meta-analysis-finds.htm
1 Mar 2023
Wellness group, redirection of patients to other services aided COVID-19 response
Group meetings and individual coaching helped hospitalists at one facility deal with COVID-19 stress, a study showed, while another described how redirecting some common medicine diagnoses to admission by other services reduced the pressure of pandemic patient surges.
https://acphospitalist.acponline.org/archives/2023/02/22/free/wellness-group-redirection-of-patients-to-other-services-aided-covid-19-response.htm
22 Feb 2023
More than 1 in 10 hospitalized COVID-19 patients had cardiac event, 2021 study finds
An analysis of 8,460 patients hospitalized with COVID-19 in January to November 2021 also found that 23.4% of those with underlying cardiac disease experienced an acute cardiac event during their admission, as did 6.2% of those without pre-existing cardiac disease.
https://acphospitalist.acponline.org/archives/2023/02/08/free/more-than-1-in-10-hospitalized-covid-19-patients-had-cardiac-event-2021-study-finds.htm
8 Feb 2023
COVID-19, other pneumonia causes associated with similar mortality after ventilation
The authors of a retrospective cohort study comparing outcomes between patients with pneumonia due to COVID-19 versus other causes said that use of mechanical ventilation in the former group should follow guidelines established for the latter.
https://acphospitalist.acponline.org/archives/2023/01/18/free/covid-19-other-pneumonia-causes-associated-with-similar-mortality-after-ventilation.htm
18 Jan 2023
Hospitals can stop testing for COVID-19 in asymptomatic patients, societies say
The Society for Healthcare Epidemiology of America, American Society of Anesthesiologists, and Anesthesia Patient Safety Foundation no longer recommend universal screening for COVID-19 before admission or surgery.
https://acphospitalist.acponline.org/archives/2023/01/04/free/hospitals-can-stop-testing-for-covid-19-in-asymptomatic-patients-societies-say.htm
4 Jan 2023
Latest COVID-19 studies look at proning awake patients, residual lung abnormalities
A meta-analysis found that prone positioning of awake patients reduced intubation rates but not mortality, while a postdischarge study estimated that about 11% of patients hospitalized for COVID-19 could have residual lung abnormalities.
https://acphospitalist.acponline.org/archives/2022/12/14/free/latest-covid-19-studies-look-at-proning-awake-patients-residual-lung-abnormalities.htm
14 Dec 2022
Screening patients, visitors, staff at hospital entrances didn't catch much COVID-19
Of nearly 1 million individuals screened for COVID-19 symptoms or exposure at entrances of a U.S. academic medical center from March 17, 2020, to May 8, 2021, fewer than 0.1% had a failed screening. The estimated cost to identify one screening failure was $2,351.
https://acphospitalist.acponline.org/archives/2022/12/07/free/screening-patients-visitors-staff-at-hospital-entrances-didnt-catch-much-covid-19.htm
7 Dec 2022
New studies assess effects of anticoagulation during, after COVID-19
Use of intermediate, full-dose, or prophylactic anticoagulation in COVID-19 inpatients wasn't associated with any difference in in-hospital mortality in one study, while another found it was safe to discontinue anticoagulation after three months in patients with a COVID-19-associated clot.
https://acphospitalist.acponline.org/archives/2022/11/16/free/new-studies-assess-effects-of-anticoagulation-during-after-covid-19.htm
16 Nov 2022
Symptoms persist long after ECMO for COVID-19, study finds
An analysis of French ICU patients who underwent extracorporeal membrane oxygenation (ECMO) for COVID-19 found that at one year, 44% had significant anxiety, 42% had depression symptoms, 42% were at risk for post-traumatic stress disorder, and only 38% had returned to work.
https://acphospitalist.acponline.org/archives/2022/10/05/free/symptoms-persist-long-after-ecmo-for-covid-19.htm
5 Oct 2022